Centene Corporation (CNC) has been garnering attention of late, shown by Atria Wealth Solutions Inc. and Kestra Private Wealth Services raising their stock holdings. Its Q1 2024 Earnings, Q2 and full-year results in 2023 showcased beating estimates and persistent growth, leading CNC to raise full-year guidance twice. The corporation has also been selected to serve New Hampshire's Medicaid Members and won a Medicaid contract to serve Michigan better. Despite some declines, CNC continues to outdo competitors on several trading days, and a raised price target by Barclays suggests bullish sentiment. Attention has also been paid to the strategic and financial strength of CNC, with the company receiving an A-Grade valuation. However, a lawsuit alleging Centene fraud was given permission to proceed. There have also been insider stock sales and management changes, including new appointments in the positions of Chief Growth Officer and Chief Operating Officer. CNC divested Circle Health Group and announced deals to tackle mental health issues and enhance value-based care. In addition, Centene's focus on membership growth and health equity imprints a positive vision for the future. Nonetheless, despite these promising developments, CNC's performance has experienced some underperformances in the market.
Centene Corporation CNC News Analytics from Thu, 13 Jul 2023 07:00:00 GMT to Fri, 10 May 2024 10:15:39 GMT -
Rating 6
- Innovation 4
- Information 8
- Rumor 7
